September 26, 2025

Old Medicine, New Hope for Speech?

Leucovorin, a folic acid–derived drug, is under study for speech benefits in children with autism.

KFF Health News

September 23, 2025

ACOG Counters Federal Acetaminophen Concerns

Steven J. Fleischman, MD, MBA, FACOG, president of the American College of Obstetricians and Gynecologists released remarks on analgesic safety for patients who are pregnant.

Conexiant

September 23, 2025

Autism Briefing Without CDC Input?

Debate over acetaminophen use in pregnancy and vaccine safety highlights the importance of evidence-based guidance for autism risk counseling.

KFF Health News

September 22, 2025

Trump Takes Dual Action on Autism Crisis

"We have a response today to the autism crisis."

Conexiant

September 19, 2025

Vaccine Playbook Rewrite: Who’s In Charge?

HHS Secretary Robert F. Kennedy Jr.’s changes at the CDC are prompting states and medical societies to issue independent vaccine recommendations, challenging long-standing national immunization policy.

KFF Health News

September 12, 2025

FDA Considers Ending Routine Advisory Committees on New Drugs

The FDA move to limit advisory committee involvement in drug approvals has prompted debate on the balance between efficiency and transparency.

KFF Health News

September 10, 2025

Prenatal Acetaminophen and ADHD/ASD: Linked?

Review of 46 human studies links prenatal acetaminophen to higher ADHD/ASD risk; evidence is heterogeneous; cohort effect sizes are generally modest but larger in some biomarker studies; authors advise cautious, short‑term use under medical guidance.

Conexiant

September 10, 2025

Medical Societies Challenge Kennedy

"That you can no longer trust the recommendations out of the CDC is just devastating."

Conexiant

September 03, 2025

CDC Leadership Changes May Impact Vaccine Guidance

Leadership changes at the CDC could affect vaccine guidance and public health policy, with potential implications for physicians and patient care.

KFF Health News